Asalyxa Bio

About:

Asalyxa Bio is committed to developing neutrophil targeting treatments for diseases with a high unmet medical need.

Website: https://www.asalyxabio.com/

Top Investors: Ann Arbor SPARK, LoftyInc Capital, Biosciences Research and Commercialization Center (BRCC), Michigan Rise, Research Bridge Partners

Description:

Asalyxa Bio is a drug development and platform technology company focused on novel therapeutics to treat major unmet medical needs caused by the dysregulation of immune signaling. With applications across a wide array of disease areas and conditions, Asalyxa Bio's platform technology enables delivery of existing and novel drugs directly into over-reactive immune cells.